Search

everythinglearnresearchcommunity

for

Search:↓

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

Anabolic steroid users may face higher risk of severe COVID-19.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Gloriosa superba poisoning can mimic severe tropical infections and cause rapid hair loss.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Minoxidil may cause heart issues in animals and humans.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Long-COVID has diverse, long-term health impacts, especially in young people.

A new IL6ST gene variant may cause a unique form of hyper-IgE syndrome with skin abscesses and high IgE levels.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

A woman with lupus and systemic sclerosis developed severe acne that didn't improve with treatment and died from pneumonia and septic shock.

Three patients suffered severe health issues due to not getting enough vitamins and minerals after weight-loss surgery.